18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer
Latest Information Update: 06 Sep 2024
At a glance
- Drugs Piflufolastat F18 (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Diagnostic use
- 04 Sep 2024 Planned number of patients changed from 330 to 800.
- 28 Nov 2023 Planned End Date changed from 1 Oct 2026 to 31 Dec 2030.
- 28 Nov 2023 Planned primary completion date changed from 1 Oct 2025 to 31 Dec 2029.